Transforming growth factor-β1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein

National Medical Journal of China

Volumn 85, Issue 5, 2005, Pages 328-331

  Huang, Hai Chang ^a   Liu, Sen Yan ^a   Liang, Yan ^a   Liu, Ying ^a   Li, Jing Zi ^a   Wang, Hai Yan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Matrix metalloproteinases; Podocyte; Transforming growth factor beta

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYTOPLASM PROTEIN; FISH OIL; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR ETS 1; TRANSFORMING GROWTH FACTOR BETA1; TRITON X 100;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PODOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SUPERNATANT; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; KIDNEY GLOMERULUS; MATRIX METALLOPROTEINASE 9; MICE; PROTO-ONCOGENE PROTEIN C-ETS-1; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 13844297572     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Noel LH. Morphological features of primary focal and segmental glomeruloselerosis. Nephrol Dial Transplant, 1999, 14 ( Suppl 3): 53-57.
2. McMillan J I, Riordan J W, Couser W G, et al. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest, 1996,97:1094-1101.
3. Urushihara M, Kagami S, Kuhara T, et al. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis. Nephrol Dial Transplant, 2002,17:1189-1196.
4. Mundel P, Reiser J, Borja AZM, et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res,1997, 236:248-258.
5. Huang HC, Liang Y, Cheng IJ. Transforming growth factor beta1 modulates connective tissue growth factor expression via Smad2 signaling pathway in podocyte in vitro. Natl Med J China,2004,84: 574-577.
6. Kriz W, Gretz N, Lemley K V. Progression of glomerular diseases: is the podocyte the culprit? Kidney Int, 1998,54:687-697.
7. Basile DP. The transforming growth factor beta sytem in kidney disease and repair: recent progress and future directions. Curr Opin Nephrol Hypertens, 1999,8:21-30.
8. Lelongt B, Legallicier B, Piedagnel R, et al. Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases? Curr Opin Nephrol Hypertens, 2001,10:7-12.
9. Ebihara I, Nakamura T, Shimada N, et al. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent Diabetes Mellitus. Am J Kidney Dis, 1998,32:544-550.
10. Santibanez JF, Guerrero J, Quintanilla M, et al. Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochem Biophys Res Common, 2002,296:267-273.
11. Fornoni A, Wang Y C, Lenz O, et al. Association of a decreased number of d(CA) repeats in the matrix metalloproteinase-9 promoter with glomerulosclerosis susceptibility in mice. J Am Soc Nephrol, 2002,13:2068-2076.
12. Zeng L, Li M, Song X, et al. Epstein barr virus latent membrane protein 1 (LMP1) activated Ets-1 expression mediated by ERK in nasopharyngeal cell line. Biochemistr Biophysical Progress, 2003, 30:574-578.
13. Naito T, Razzaque MS, Nazneen A, et al. Renal expression of the Ets-1 proto-oncogene during progression of rat crescentic glomerulonephritis. J Am Soc Nephrol, 2000,11:2243-2255.
14. Asanuma K, Shirato I, Ishidoh K, et al. Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes. Kidney Int, 2002,62:822-831.